NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIMH E-206-1999-0-US-07 Novel Gabab Receptor DNA Sequences US CON 10/983,198 Abandoned
NCI E-018-2002-0-IL-04 Application of Spliceosome-Mediated RNA Trans-Splicing (SMART tm) Gene Therapy To The Treatment of Human Papillimavirus... IL National Stage 165057 Expired
NIDCR E-114-2003-0-PCT-02 Methods And Composition for the Inhibition of HIV -1 Replication PCT PCT PCT/US2004/36492 Expired
NIA E-108-2006-0-US-01 Compound Useful In The Treatment Or Prevention Of Cognitive Disorders Associated With Diabetes And Associated Methods US 60/624,717 Abandoned
NCI E-299-2004-0-US-01 Crimean-Congo Hemorrhagic Fever Virus Glycoproteins And Soluble Peptide Fragments Thereof As Antigens, Immunogens And Inhibitors US 60/624,783 Abandoned
NCI E-065-2005-0-US-01 Novobiocin Analogues as Anticancer Agents US 60/624,566 Abandoned
NHLBI E-183-2004-0-US-01 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS US 60/624,803 Abandoned
NIAID E-066-2003-4-US-01 Monoclonal Antibodies that Bind or Neutralize Dengue Virus US 60/624,261 Abandoned
NCI E-049-2006-0-US-01 Combination Approaches For Generating Immune Responses US 60/624,506 Abandoned
NCI E-004-2005-0-US-01 Human Monoclonal Antibodies Against Hendra And Hipah Viruses US 60/624,247 Abandoned
NCI E-251-2004-0-US-01 Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies US 60/623,394 Abandoned
NIAID E-333-2004-0-US-01 Structured-Based Enchancement of CD4-Molecular Mimicry Leads to Increase Breadth of HIV Neutralization US 60/623,762 Abandoned
NICHD E-166-2004-1-US-01 Themostable Y-Family Polymerases and Chimeras US 60/623,490 Abandoned
NIAID E-312-2003-0-PCT-02 Use Of Statin to Kill EBV-Transformed B Cells PCT PCT PCT/US2004/35829 Expired
NCI E-152-2002-0-US-03 QUANTITATIVE ASSAY OF THE ANGIOGENIC AND ANTIANGIOGENIC ACTIVITY OF A TEST MOLECULE. US National Stage 10/510,652 Abandoned
NCI E-001-2005-0-CA-03 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof As Antimetastatic Agents In Treating Cancer CA National Stage 2545276 Abandoned
NCI E-001-2005-0-IT-10 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof As Antimetastatic Agents In Treating Cancer IT EP 04818605.0 Abandoned
NCI E-001-2005-0-GB-09 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof As Antimetastatic Agents In Treating Cancer GB EP 04818605.0 Abandoned
NCI E-001-2005-0-ES-07 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof As Antimetastatic Agents In Treating Cancer ES EP 04818605.0 Abandoned
NCI E-001-2005-0-DE-06 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof As Antimetastatic Agents In Treating Cancer DE EP 04818605.0 Abandoned
NCI E-001-2005-0-FR-08 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof As Antimetastatic Agents In Treating Cancer FR EP 04818605.0 Abandoned
NCI E-001-2005-0-EP-02 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof As Antimetastatic Agents In Treating Cancer EP National Stage 04818605.0 Abandoned
NCI E-001-2005-0-AU-04 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof As Antimetastatic Agents In Treating Cancer AU National Stage 2004289210 Abandoned
NCI E-001-2005-0-PCT-01 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof As Antimetastatic Agents In Treating Cancer PCT PCT PCT/US2004/35831 Expired
NHLBI E-338-2007-2-US-01 Methods And Apparatus For Creating Particle Derivatives Of HDL With Reduced Lipid Content US 60/622,930 Abandoned
NIDDK E-045-2005-1-US-01 METHODS OF USING GLYCOSAMINOGLYCANS FOR THE TREATMENT OF KIDNEY DISEASE US 60/622,332 Abandoned
NCI E-124-2004-1-US-01 Diagnostic Tool For Diagnosing Benign Versus Malignant Thyroid Lesions US 60/622,643 Abandoned
NCI E-137-2002-0-IN-08 METHOD FOR TREATING CANCER IN HUMANS IN National Stage 02429/CHENP/04 Abandoned
NIDA E-087-2002-0-JP-08 Methods fo rPreventing or Treating Cardiac Arrhythmia JP National Stage 2003-570777 Expired
NCI E-021-1998-0-US-08 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods For Their Use US DIV 10/973,718 7368110 Expired PDF
NCI E-007-2004-0-CA-03 Pyrrolobenzodiazepine Derivatives, Compositions Comprising the Same and Methods Related Thereto CA National Stage 2543318 Abandoned
NCI E-007-2004-0-EP-05 Pyrrolobenzodiazepine Derivatives, Compositions Comprising the Same and Methods Related Thereto EP National Stage 04817338.9 Abandoned
NIAMS E-209-2005-0-PCT-01 Pyrrolobenzodiazepines PCT PCT PCT/US04/004497 Abandoned
NCI E-007-2004-0-PCT-02 Pyrrolobenzodiazepine Derivatives, Compositions Comprising the Same and Methods Related Thereto PCT PCT PCT/US2004/35050 Expired
NIA E-172-2004-0-US-01 Tricyclic Compounds and Methods of Making and Using Therof US 60/621,287 Abandoned
NCI E-007-2004-0-AU-04 Pyrrolobenzodiazepine Derivatives, Compositions Comprising the Same and Methods Related Thereto AU National Stage 2004284075 Abandoned
NCI E-137-2002-0-BE-17 METHOD FOR TREATING CANCER IN HUMANS BE EP 03745667.0 Abandoned
NCI E-137-2002-0-CH-12 METHOD FOR TREATING CANCER IN HUMANS CH EP 03745667.0 Abandoned
NCI E-137-2002-0-GB-15 METHOD FOR TREATING CANCER IN HUMANS GB EP 03745667.0 Abandoned
NCI E-137-2002-0-IT-16 METHOD FOR TREATING CANCER IN HUMANS IT EP 03745667.0 Abandoned
NCI E-137-2002-0-FR-14 METHOD FOR TREATING CANCER IN HUMANS FR EP 03745667.0 Abandoned
NCI E-137-2002-0-DE-13 METHOD FOR TREATING CANCER IN HUMANS DE EP 03745667.0 Abandoned
NIAID E-089-2002-1-US-02 Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 US National Stage 10/970,640 7517531 Expired PDF
NIA E-183-2003-0-RU-18 Method For Treating Cognitve Disorders RU National Stage 2004131214 Abandoned
NCI E-299-2004-1-US-01 Soluble Forms Of The Crimean-Congo Hemorrhagic Fever (CCHF) Virus G1 And G2 Proteins US 60/620,833 Abandoned
NIAID E-227-2001-0-US-03 Brother of The Regulator of Imprinted Sites (Boris) US National Stage 10/505,377 7375206 Expired PDF
NICHD E-355-2003-2-US-02 Antileishmanial Sulfonamide Componds With Activity Against Parasite Tubulin US National Stage 10/512,335 Abandoned
NCI E-263-2004-0-US-01 POT1 Alternative Splicing Variants US 60/620,754 Abandoned
NCI E-311-2004-0-US-01 Methods and Compositions For Protecting Cells From Ultrasound Induced Cytolysis US 60/620,258 Abandoned
ORS E-190-2004-0-US-01 Apparatus and Method For Decontamination US 60/620,095 Abandoned